Ocular Therapeutix Inc
OCUL
Market Cap$2.12B
Close$
$10.44
23.2% downside
Current Fair Value
23.2% downsideOvervalued by 23.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.12 Billion |
|---|---|
| Enterprise Value | $1.81 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.22 |
| Beta | 1.49 |
| Outstanding Shares | 172,594,662 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.72 |
|---|---|
| PEG | -17.71 |
| Price to Sales | - |
| Price to Book Ratio | 13.6 |
| Enterprise Value to Revenue | 32.03 |
| Enterprise Value to EBIT | -8.11 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.25 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Ocular Therapeutix Inc
CEO: Antony Mattessich